Showing 1672 results
-
Story /Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
-
Press release /Q3 net sales (-1% cc[2] and USD) broadly in line with prior year due to strong performance of Growth Products Gilenya (USD 790 million, +15% cc) continued double-digit growth Cosentyx (USD 301…
-
Story /New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
-
Press release /Solid growth (cc[1]) in Q3 sales, core operating income, core EPS for continuing operations[2] Net sales were USD 12.3 billion (-6%, +6% cc) Operating income was USD 2.2 billion (-18%, +2% cc) Core…
-
Story /Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.
-
In The News /Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.
-
Story /COPD receives low attention as a women’s health issue. It’s time to change that.
-
Press release /Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025DTP offering to expand to other appropriate products;…
-
Press release /reSET-OTM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics is leading the development of a new therapeutic class with two…
-
Story /Sharing Key Insights and Lessons to Accelerate Progress.